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INTRODUCTION
 Postprandial increase in oxidative stress induced 
by food intake in the body is associated with 
increased glucose concentration, triglyceride 
and oxidative pressures.1-3 Damage to cellular 
structures including proteins, carbohydrates and 
fats can be due to the increased oxidative activity 
during this stage.1,3 High-fat diet can affect the 
trigger mechanisms of atherosclerosis, because 
it causes acute changes in vessel’s endothelial 
cells.1-3 Antioxidants may be useful at the time of 
postprandial oxidative stress through preventing 
the vulnerability of organism. Lipid or carbohydrate-
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ABSTRACT
Background and Objective:	High-fat	diet	causes	a	sudden	increase	 in	blood	lipids	and	oxidative	stress	
after each meal, which can affect the trigger mechanisms of atherosclerosis and cause some acute changes 
in	the	function	of	vessels’	endothelial	cells.	With	respect	to	the	antioxidant	properties	of	Sumac	(Rhus 
coriaria), the present research was conducted to determine the effect of taking Sumac along with food on 
some	atherosclerosis	risk	factors	resulting	from	high-fat	diet	in	hypercholesterolemic	rabbits.	
Methodology:	In	this	experimental	study,	24	New	Zealand	rabbits	were	randomly	designated	into	three	
eight-member	groups	as	follows:	normal	diet,	high-cholesterol	diet	(1%),	high-cholesterol	diet	and	Sumac	
powder	2%.	Oxidative	 stress	 factors	and	 those	 influencing	atherosclerosis	or	arterial	 function	 including	
glucose,	 total	 cholesterol	 (TC),	 triglyceride	 (TG),	 Apo	 lipoprotein	 B	 (Apo	 B),	 low-density	 lipoprotein	
(LDL-C),	nitrate,	nitrite,	fibrinogen	and	factor	VII,	and	also	liver	enzymes	(ALT,	AST)	were	measured	and	
compared in each group.
Results:	High	cholesterol	diet	significantly	increased	total	cholesterol,	fibrinogen,	triglycerides,	glucose,	
nitrate,	LDL-C	and	the	liver	enzymes	ALT	and	AST	(p	<	0.05).	Use	of	powdered	Sumac	revealed	a	significant	
decrease	in	the	blood	levels	of	glucose	(30.15%),	LDL-C	(58.17%),	total	cholesterol	(29.5%),	ALT	(17.46%),	
AST	(20.55%)	and	fibrinogen	(17.92%)	compared	to	the	high-cholesterol	diet	group	(p	<0	.05),	but	did	not	
induce	any	significant	changes	on	triglyceride	(TG),	factor	VII,	nitrite,	nitrate	and	ApoB	(p	>	0.05).
Conclusions:	This	study	demonstrates	the	protective	effect	of	consuming	Sumac	with	food	on	some	risk	
factors	of	atherosclerosis	and	oxidative	stress	(glucose,	LDL-C,	total	cholesterol	and	fibrinogen)	and	also	
liver	enzymes	induced	by	high	fat	food.
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rich food will be the target of oxidative changes 
after absorption or presenting in peroxidative 
form in foodstuff.3,4 Sumac contains antioxidants, 
flavonoids, and hydrolysable tannins which 
have anticancer, anti-tumor and hypoglycemic 
properties.5-10 Long-term consumption of Sumac 
reduces the cholesterol level.11 The glycoprotein 
extracted from the fruit of Sumac also reduces the 
total cholesterol, triglycerides, LDL-C and increases 
the antioxidant capacity.12 Fruit of some other plants 
such as blueberry which has antioxidant activity 
causes the dilatation of coronary and systemic 
arteries, inhibits platelet aggregation and reduces 
vascular permeability in hypercholesterolemic 
rabbits13-16 and may also improve blood flow.17
 Researches in recent years, other than old markers’ 
role, have considered new markers such as Apo 
lipoprotein B (Apo B), nitrate, nitrite, fibrinogen 
and factor VII in the formation of atherosclerosis. 
High concentrations of some plasma lipoproteins 
such as VLDL, LDL and IDL are associated with 
the progression of atherogenesis.17-21 Lipoproteins 
containing Apo B-100 have also been known as 
the carrier of cholesterol into the arterial wall.22-
24 Reports also indicate a relationship between 
coagulation system components (fibrinogen and 
factor VII) or fibrinolytic factors (t-PA and PAI-1) 
and atherosclerosis.25-27 Fibrinogen is a circulating 
glycoprotein that works in the stages of coagulating 
response to vascular and tissue damage. There is a 
correlation between plasma fibrinogen levels and 
risk of coronary disease.23 Despite the thrombosis 
role, fibrinogen causes vasoconstriction at the injured 
sites of the vessel wall, stimulation of the platelet 
aggregation and regulation of cell adhesion.24-26 
Factor VII is a coagulating protein which plays 
an important role in thrombogenesis. There is a 
relationship between factor VII and inflammatory 
parameters (CRP and IL6) in hypercholesterolemic 
patients, which represent their pathophysiologic 
relationship in these patients.27,28
 Although the main mechanism affecting the 
endothelium consists of several factors, the most 
important factor is disorder in the eNOS/NO 
pathway that includes reduction in expression 
and activity of eNOS and reduction of sensitivity 
to NO and increased NO destruction by reaction 
with superoxide. With regard to the expression of 
eNOS in the vessel wall, eNOS level is reduced in 
advanced atherosclerosis, which is probably due to 
the reduced translation or increased eNOS mRNA 
instability.27,28 Endothelium-dependent dilation 
happens in atherosclerotic vessels even before 
occurrence of any change in the vascular structure 
and expresses the eNOS reduction. It is known that 
under certain pathologic conditions such as severe 
hypercholesterolemia, eNOS is disturbed and 
nitrite peroxide is produced instead of NO.27,28
 In view of the side effects of synthetic drugs and 
individuals’ high tendency to the use of herbal 
medicines and considering the fact that Sumac has 
antioxidant properties and its long-term intake 
reduces cholesterol, this study was conducted to 
determine the effect of consuming Sumac with 
food on some newly proposed atherosclerosis risk 
factors (in addition to the old ones) and also liver 
health indicators (ALT, AST) resulted from high-fat 
diet stress.
METHODOLOGY
 In this study, Sumac was purchased from a 
local market in Shahrekord and authenticated in 
herbarium unit of Medical Plants Research Center 
of Shahrekord University of Medical Sciences. 
A voucher specimen (no. 268) was deposited 
there. The Sumac fruit was dried under standard 
conditions away from sunlight, moisture, microbial 
contamination with appropriate air-conditioning, 
and the plant was well powdered by electrical mill, 
after drying. In order to standardize the powdered 
Sumac, some factors such as anthocyanins29 and 
polyphenols were measured as follows30: One gram 
of powder and 100 ml of ethanol 95% and 1.5 ml 
normal hydrochloric acid were poured in a 250 
ml erlen and covered with Parafilm and kept in 
refrigerator at 2-4 centigrade degrees for 12 hours. 
Then, the mixture was filtered and its extract was 
separated and the residue was repeatedly washed 
with acidic ethanol solvent, and finally the volume 
of the solution was brought to 250 ml. Then, its 
absorption was determined in a one-centimeter cell 
in the wavelength of 535 nm and its anthocyanin 
content was measured by the following formula:
A/98.2×25000=The total anthocyanin level (mg per 
100 grams of sample).19
A=Absorbance sample
Measurement of phenolic compounds: The total 
amount of phenolic compounds was measured 
based on Folin-Ciocalteu colorimetric method, 
equivalent to Gallic acid. At first, standard 
solutions with concentrations of 12.5, 25, 50, 62.5, 
100 and 125 ppm were obtained from Gallic acid 
in 60% methanol solution. Then 0.1 ml of each was 
transferred to test tubes and 0.05 ml of 10% reactive 
solution of Folin-Ciocalteu was added. Then, after 
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five  minutes, 0.4 ml of 7.5% sodium carbonate was 
added to the solution. The tubes were kept at room 
temperature for 30 minutes and the absorption 
level was measured by spectrophotometer for three 
times at the wavelength of 765 nm. Then, 10 mg 
of the extract was dissolved in 60% methanol and 
brought into 10 ml and the level of total phenol 
content was determined using Folin-Ciocalteu 
colorimetric method. Then based on the observed 
uptake, the amount of total phenols was obtained 
in terms of mg/g of the extract.30
Animal experiments: In this experimental study, 
24 New Zealand white rabbits weighing 2015±34 
grams were bought from Razi Institute, Karaj, Iran. 
They were acclimated in the animals’ nest for two 
weeks in appropriate temperature and humidity, 
fed with standard grain food (Razi Co., Karaj). 
Then, animals were randomly divided into three 
eight-member groups as follows: normal diet, 
high-cholesterol diet (1%), high-cholesterol diet 
with 2% powdered Sumac (2% Sumac powder 
was added to the rabbit food). In order to provide 
high-cholesterol diet (1%), one gram of cholesterol 
(Merck, Germany) was dissolved in 2ml olive oil 
and was added to regular rabbit food in order to 
provide 100 grams of high-cholesterol diet. Rabbits 
of the high-cholesterol diet group and high-
cholesterol diet along with intervention (powdered 
Sumac) were treated with this food. Blood 
samples were taken from animals in two stages 
including the beginning of the experiment (after 15 
hours of fasting) and three hours after taking the 
intervention diets.31,32 At the fasting time, blood 
samples were collected from the central artery 
of animals’ ear and at the end of the experiment, 
from the animals’ heart. The blood taken from 
the rabbits was poured into two separate tubes in 
order to obtain serum and plasma (containing 0.5 
cc of sodium citrate). In order to prepare serum and 
plasma, tubes were centrifuged for 20 minutes with 
3500 rpm. Nitrite and nitrate were measured  using 
Griess Reaction method, with the relevant kit (R 
& D System company, USA), fibrinogen, glucose, 
total cholesterol, LDL cholesterol, triglycerides 
(TG), alanine aminotransferase (ALT), aspartate 
aminotransferase (AST) and apo lipoprotein B (Apo 
B) by biochemical kits of the Pars test company 
using Hitachi 902 auto-analyzer device (Japan) and 
factor VII by measuring the clotting time in the 
presence of Neoplastin reagent, with STA-Deficient 
VII kit, (Diagnostica Stago company, France) using 
start-4 coagulator device.
Statistical Analysis: To evaluate the biochemical 
results and compare the test groups, one-way 
ANOVA and Dunnett post hoc tests were used. The 
results were calculated as Mean±SE in all cases and 
p<0.05 was considered as significant.
RESULTS
 The level of physicochemical parameters meas-
ured in Sumac: The amount of anthocyanins in 
Sumac was 23.7 mg per 100 grams and the amount 
of its flavonoids and phenolic compounds were re-
spectively 45 and 89 mg per 100grams, equivalent 
to Gallic acid. The amount of biochemical mark-
ers measured in rabbits: The levels of glucose, tri-
glycerides, fibrinogen, LDL-C, TC, AST, and ALT 
were significantly increased in the high-cholesterol 
group compared to the normal diet group. Con-
suming powdered Sumac revealed a significant de-
crease in blood glucose level compared to the high-
cholesterol diet group (p<0.05; Table-I). Regarding 
the lipid profile, consumption of Sumac revealed 
a significant reduction in LDL-C and cholesterol 
levels (p<0.05) compared to the high-cholesterol 
diet group. Consuming Sumac did not induce any 
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Table-I: Values of biochemical factors in experimental groups at the end of trial.
Biochemical factors Groups
 Normal diet High-cholesterol diet Sumac
Low-density lipoprotein 24.13±1.26* 39.31±3.20 16.44±1.37*
Fibrinogen (mg/dl) 218.9±2.6* 251±4.6 206.1±2.2*
TG (mg/dl) 50.50±1.43* 120.56±5.45 127.33±5
Total cholesterol 56.63±0.68* 91±3.37 63.56±2.07*
Alanine amino-transferase (u/l) 26.63±0.50* 40±1.34 31.78±1.40*
Glucose (mg/dl) 51.25±3.12* 132±3.07 102.33±3.22*
Aspartate amino-transferase (u/l) 29.75±0.53* 43.22±2.62 35.67±1*
Apo-lipoprotein (mg/dl) 27.88±1.42 30.78±1.02 28.89±1.42
Nitrate 305±108.6* 430±36.7 416±65
Nitrite 250.4±10 249.3±10.4 179±50.6
Factor VII 295.7±2.5 298.1±5.7 298.7±5.9
-*p<0.05 compared to the high-cholesterol group
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significant change on triglycerides (TG) and ApoB 
(p>0.05; Table-I). Consuming Sumac significantly 
decreased the level of liver enzymes (ALT, AST) 
(p<0.05; Table-I). Considering the inflammatory 
markers, Sumac consumption significantly reduced 
the fibrinogen level, but had no effect on factor VII 
level (p>0.05; Table-I).Considering the endothelial 
markers (nitrite and nitrate), although the amount 
of nitrite and nitrate was decreased due to con-
sumption of Sumac in comparison with the high-
cholesterol diet, the decrease was not statistically 
significant (p>0.05; Table-I).
DISCUSSION
 Consuming foods that contain 1% cholesterol 
increased the total cholesterol, fibrinogen, 
triglyceride, glucose, nitrate, LDL, liver enzymes 
ALT and AST, and using powdered Sumac along 
with high-cholesterol diet revealed a significant 
decrease in the level of glucose (30.15%), LDL -C 
(58.17%), total cholesterol (29.5%), ALT (20.55%), 
AST (17.46%) and fibrinogen (17.92%) compared to 
the high-cholesterol diet group (p<0.05). Research 
has shown that consumption of high fat foods causes 
a relatively rapid increase in blood lipids, increased 
lipid per-oxidation and aggravation of endothelial 
function destruction which can be blocked by 
antioxidants.33 The hypocholesterolemic effects 
of the Sumac and the effect of the glycoprotein 
extracted from Sumac fruit in lowering total 
cholesterol, triglycerides and LDL-C have been 
previously reported.11,12
 The present study showed that taking Sumac 
along with high-fat foods can prevent the transient 
increase of postprandial blood fat which is highly 
atherogenic. The level of liver enzymes (ALT, 
AST) also increased with high fat food intake 
and decreased with Sumac consumption in this 
study. The increase in these enzymes following 
the consumption of high-fat food shows the 
hepatotoxicity of high-fat foods. The reduction of 
liver enzymes with Sumac consumption after high-
cholesterol meals can show the preventive effect of 
Sumac against hepatic damage.
 Increased cholesterol or triglyceride and decreased 
HDL concentrations leads to the production of 
free radicals and oxidative stress accompanied by 
atherosclerosis aggravation and vascular damage 
through affecting the Arachidonic acid metabolism 
and leukocyte stimulation.34 Increased production 
of free radicals and oxidative stress reduces the 
nitric oxide synthesis in endothelial cells. Reduced 
nitric oxide hurts the endothelium-dependent 
relaxation of smooth muscles and makes the vessel 
susceptible to plaque formation.35
 The direct role of increased free radicals in the 
development and progression of atherosclerosis 
proposes the antioxidants as highly effective factors 
in disease prevention.36 Phenolic compounds 
and anthocyanins, whose presence in Sumac was 
shown in this study, have antioxidant effects and 
can confront the destructive effects of free radicals 
caused by consuming high-fat meal. Isoflavones 
reduce cholesterol levels by increasing the LDL 
receptors’ activity and increasing the LDL catabolism 
in liver.37 The presence of isoflavones in Sumac36 
sets forth the possibility of such mechanisms for 
the effect of this herb. High blood sugar in diabetic 
patients causes frequent complications such as 
ocular and vascular diseases. Deposition of collagen 
and glycoproteins in blood vessel wall causes the 
vessel wall thickening and consequences resulting 
from atherosclerosis. Therefore, the hypoglycemic 
effect of Sumac can be considered as a beneficial 
factor in reducing atherosclerosis.
 Flavonoids existing in Sumac may prevent 
diabetes complications by hindering the Aldose 
reductase activity (the enzyme that converts sugar 
to sugar-alcohol or sorbitol).38 Flavonoids also 
inhibit the function of intestinal carriers of glucose 
and prevent glucose absorption.39 Another possible 
mechanism of phenolic compounds is their effects 
on glucose 6-phosphatase inhibition. The enzyme 
removes phosphate from esterified glucose. This 
will lead to glucose release in blood. As a result, the 
reduction or stopping of the activity of this enzyme 
will reduce blood sugar.40 Therefore, blood glucose 
reduction can be attributed to the flavonoids in 
the Sumac. Potential mechanism of polyphenols 
is reducing the digestion absorption of fat and 
lipase activity in stomach.41,42 In this regard it has 
also been reported that Catechin rich polyphenols 
can significantly inhibit the emulsification and 
also inhibit the activity of the lipase in pancreas, 
stomach and duodenum.43 Impaired fibrinolysis 
and coagulation is correlated with the progress of 
cardiovascular diseases such as coronary artery 
disease, hypertension, and ischemic shock.44 
 Fibrinogen plays an important role in the 
complication of the atherosclerosis process as a 
coagulation and inflammatory factor. Fibrinogen 
oxidation and other residues resulting from 
fibrinogenase stimulate platelet aggregation and 
increase IL-6.45,46 Studies show the effect of herbal diet 
in the homeostasis of coagulation and fibrinolysis 
process. These compounds are effective in reducing 
the concentration of coagulation factors or increasing 
fibrinolysis. Some of the herbal compounds are 
involved in this process through preventing blood 
from clotting by reducing fibrinogen, increasing 
fibrinolysis, prothrombin time and inhibiting 
platelet aggregation. Flavonoids such as quercetin, 
kaempferol and myricetin are among flavonoids 
that inhibit platelet aggregation.47 Polyphenols are 
rapidly absorbed, which leads to their increased 
concentration in blood and induction of mRNA 
expression and fibrinolytic proteins such as t-PA 
and PAI down regulation.48 Factor VII activity is 
correlated with the increased risk of cardiovascular 
disease. Increased activity of this factor after high 
fat meal is due to the increased level of VII protein. 
Factor VII can be acutely set and adjusted by food.
 Flavonoids bring about the reduction of coagu-
lation factors such as factor VII.49 The lack of de-
crease in factor VII in this research can be due to 
the short duration of the study, since its synthesis 
in the liver needs sufficient time. The results of this 
study showed that Sumac significantly decreases 
the levels of SGOT and SGPT. The level of these 
enzymes is increased after a heart attack, liver dis-
eases and diseases that cause muscle damage.50 Na-
deri et al.’s studies in 2007 showed that the antioxi-
dant compounds of black pepper lead to reduction 
of SGPT to 33% in rat liver cells by affecting lipid 
oxidation in LDL.51 Therefore, reduction of SGOT 
and SGPT levels in the high-cholesterol group that 
received Sumac diet may be due to the antioxidant 
effects of such plants.Anthocyanins preserve en-
dothelial cells through inhibition of nitrite peroxide 
that leads to oxidative damage. Anthocyanins act 
through reducing the expression of iNOS. iNOS is 
an enzyme produced by different cells by cytokines 
during inflammatory stress.
 It seems that anthocyanins have contradictory 
effects on Nos isoforms. According to studies, 
NO production by eNOS has an important role in 
initiation of coronary arteries’ homeostasis, whereas 
NO production by iNOS can lead to coronary artery 
diseases. Therefore, anthocyanins play an important 
role in establishing balance between eNOS and 
iNOS.52-55
CONCLUSION
 The results showed that Sumac consumption 
reduces the risk factors for atherosclerosis. This can 
be achieved through inhibition of oxidative stress 
and lipid peroxidation. This study proves the anti-
inflammatory and hypolipidemic activity of the 
Sumac. The hypoglycemic property of Sumac was 
also confirmed in this study. Since blood glucose 
is correlated with increased oxidative stress, this 
effect can also prove the supportive effect of the 
Sumac.
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